Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Valentina Vladimirova"'
Autor:
David Krug, Valentina Vladimirova, Michael Untch, Thorsten Kühn, Andreas Schneeweiss, Carsten Denkert, Beyhan Ataseven, Christine Solbach, Bernd Gerber, Hans Tesch, Michael Golatta, Sabine Seiler, Jörg Heil, Valentina Nekljudova, Johannes Holtschmidt, Sibylle Loibl
Publikováno v:
Breast, Vol 74, Iss , Pp 103701- (2024)
Background: Neoadjuvant chemotherapy (NACT) is routinely used for patients with triple-negative breast cancer (TNBC). Upfront breast-conserving therapy (BCT) consisting of breast-conserving surgery (BCS) and adjuvant radiotherapy (RT) has been shown
Externí odkaz:
https://doaj.org/article/8d2a63a4c8bd4f918241d9bea3fb337a
Autor:
Jonas Leichsenring, Valentina Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, Jana Barinoff, Volkmar Müller, Jens-Uwe Blohmer, Christian Schem, Knut Engels, Frederik Marmé, Annette Fisseler-Eckhoff, Peter A. Fasching, Elmar Stickeler, Marion van Mackelenbergh, Carsten Denkert, Albrecht Stenzinger, Sibylle Loibl, Stefan Gröschel
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Overexpression of the EVI1 (ecotropic viral integration site 1) oncogene has recently been implicated as a prognostic factor in breast cancer (BC), particularly in triple-negative BC (TNBC). In this study we aimed to investigate f
Externí odkaz:
https://doaj.org/article/c3d9b3683e1d4e1b93d349f80d056d05
Autor:
Christine Stürken, Volker Möbus, Karin Milde-Langosch, Sabine Schmatloch, Peter A. Fasching, Josef Rüschoff, Elmar Stickeler, Rolf-Peter Henke, Carsten Denkert, Lars Hanker, Christian Schem, Valentina Vladimirova, Thomas Karn, Valentina Nekljudova, Claus-Henning Köhne, Frederik Marmé, Udo Schumacher, Sibylle Loibl, Volkmar Müller
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Breast cancer (BC) is the most frequent female cancer and preferentially metastasizes to bone. The transcription factor TGFB-induced factor homeobox 1 (TGIF) is involved in bone metabolism. However, it is not yet known whether TGI
Externí odkaz:
https://doaj.org/article/c69ff00bda2f4529a85614e57c4f1988
Autor:
Christine Stürken, Volker Möbus, Karin Milde-Langosch, Sabine Schmatloch, Peter A. Fasching, Josef Rüschoff, Elmar Stickeler, Rolf-Peter Henke, Carsten Denkert, Lars Hanker, Christian Schem, Valentina Vladimirova, Thomas Karn, Valentina Nekljudova, Claus-Henning Köhne, Frederik Marmé, Udo Schumacher, Sibylle Loibl, Volkmar Müller
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-1 (2021)
Externí odkaz:
https://doaj.org/article/c9d26cf8ebe64f5d8bb80d323fe092e0
Autor:
Valentina Vladimirova, Thomas Mikeska, Andreas Waha, Niels Soerensen, Jingying Xu, Patrick C. Reynolds, Torsten Pietsch
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 11, Iss 7, Pp 700-711 (2009)
High-grade gliomas (HGGs) of childhood represent approximately 7% of pediatric brain tumors. They are highly invasive tumors and respond poorly to conventional treatments in contrast to pilocytic astrocytomas, which usually are well demarcated and fr
Externí odkaz:
https://doaj.org/article/9de070dbd6e347bd87967fe4e3a00521
Autor:
David Krug, Valentina Vladimirova, Michael Untch, Thorsten Kühn, Andreas Schneeweiss, Carsten Denkert, Beyhan Ataseven, Christine Solbach, Bernd Gerber, Hans Tesch, Michael Golatta, Sabine Seiler, Jörg Heil, Valentina Nekljudova, Sibylle Loibl
Publikováno v:
Cancer Research. 83:PD15-06
Background: Neoadjuvant chemotherapy (NACT) is standard of care for patients with triple-negative breast cancer (TNBC). Treatment response, especially pathologic complete response (pCR), is a strong predictive factor for treatment outcome. In the set
Autor:
Jonas, Leichsenring, Valentina, Vladimirova, Christine, Solbach, Thomas, Karn, Beyhan, Ataseven, Bruno Valentin, Sinn, Jana, Barinoff, Volkmar, Müller, Jens-Uwe, Blohmer, Christian, Schem, Knut, Engels, Frederik, Marmé, Annette, Fisseler-Eckhoff, Peter A, Fasching, Elmar, Stickeler, Marion, van Mackelenbergh, Carsten, Denkert, Albrecht, Stenzinger, Sibylle, Loibl, Stefan, Gröschel
Publikováno v:
BMC cancer 22(1), 1040 (2022). doi:10.1186/s12885-022-10109-1
BMC cancer 22(1), 1040 (2022). doi:10.1186/s12885-022-10109-1
Published by BioMed Central, London
Published by BioMed Central, London
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e67b848814a047887c24966738d035fa
https://opus4.kobv.de/opus4-fau/files/21400/s12885-022-10109-1.pdf
https://opus4.kobv.de/opus4-fau/files/21400/s12885-022-10109-1.pdf
Autor:
Anja Kathrin Wege, Eva‐Maria Rom‐Jurek, Paul Jank, Carsten Denkert, Peter Ugocsai, Christine Solbach, Jens‐Uwe Blohmer, Bruno Sinn, Marion Mackelenbergh, Volker Möbus, Andreas Trumpp, Elisabetta Marangoni, Nicole Pfarr, Christoph Irlbeck, Jens Warfsmann, Bernhard Polzer, Florian Weber, Olaf Ortmann, Sibylle Loibl, Valentina Vladimirova, Gero Brockhoff
Publikováno v:
International journal of cancerREFERENCES. 150(8)
Estrogen receptor-positive breast cancer is a highly prevalent but heterogeneous disease among women. Advanced molecular stratification is required to enable individually most efficient treatments based on relevant prognostic and predictive biomarker
Autor:
Lars Hanker, Udo Schumacher, Volkmar Müller, Frederik Marmé, Valentina Nekljudova, Peter A. Fasching, Rolf-Peter Henke, Christian Schem, Valentina Vladimirova, Sibylle Loibl, Karin Milde-Langosch, Sabine Schmatloch, Thomas Karn, Elmar Stickeler, Volker Möbus, Christine Stürken, Claus-Henning Köhne, Josef Rüschoff, Carsten Denkert
Publikováno v:
BMC cancer 21(1), 920 (2021). doi:10.1186/s12885-021-08656-0
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC cancer 21(1), 920 (2021). doi:10.1186/s12885-021-08656-0
Published by Springer, Berlin ; Heidelberg
Published by Springer, Berlin ; Heidelberg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2369003b5100c335d479a6cbb4ec4f6e
https://publications.rwth-aachen.de/record/851063
https://publications.rwth-aachen.de/record/851063
Autor:
Anja Kathrin Wege, Valentina Vladimirova, Christine Solbach, Eva-Maria Rom-Jurek, Jens-Uwe Blohmer, Paul Jank, Bruno Sinn, Andreas Trumpp, Elisabetta Marangoni, Knut Engels, Wilko Weichert, Nicole Pfarr, Christoph Irlbeck, Bernhard Polzer, Olaf Ortmann, Marion van Mackelenbergh, Carsten Denkert, Sibylle Loibl, Gero Brockhoff
Publikováno v:
Cancer Research. 82:PD9-07
Background: Luminal, i.e., estrogen receptor (ER)-positive breast cancer (BC) is a heterogeneous disease in terms of tumor progression, therapy response, and relapse. Additional biomarkers with a prognostic and predictive impact would facilitate adva